StockNews.com started coverage on shares of Gaia (NASDAQ:GAIA – Free Report) in a report published on Wednesday morning. The brokerage issued a buy rating on the stock.
Separately, Lake Street Capital lifted their price objective on shares of Gaia from $6.00 to $7.00 and gave the company a “buy” rating in a research report on Tuesday, November 5th.
Read Our Latest Stock Analysis on Gaia
Gaia Price Performance
Gaia (NASDAQ:GAIA – Get Free Report) last issued its quarterly earnings data on Monday, November 4th. The company reported ($0.05) earnings per share for the quarter, beating the consensus estimate of ($0.06) by $0.01. The firm had revenue of $22.16 million for the quarter. Gaia had a negative net margin of 7.23% and a negative return on equity of 6.90%. Equities analysts forecast that Gaia will post -0.24 earnings per share for the current year.
Institutional Trading of Gaia
Several hedge funds have recently bought and sold shares of GAIA. Connor Clark & Lunn Investment Management Ltd. bought a new stake in shares of Gaia during the 3rd quarter worth about $49,000. Geode Capital Management LLC raised its position in shares of Gaia by 13.9% during the 3rd quarter. Geode Capital Management LLC now owns 179,050 shares of the company’s stock worth $872,000 after buying an additional 21,870 shares in the last quarter. Finally, Dimensional Fund Advisors LP raised its position in shares of Gaia by 4.3% during the 2nd quarter. Dimensional Fund Advisors LP now owns 338,638 shares of the company’s stock worth $1,493,000 after buying an additional 13,865 shares in the last quarter. 40.53% of the stock is currently owned by institutional investors.
About Gaia
Gaia, Inc operates a digital video subscription service and online community for underserved member base in the United States, Canada, Australia, and internationally. The company has a digital content library with various titles in Spanish, German, and French languages available to its subscribers on internet connected devices.
Read More
- Five stocks we like better than Gaia
- Industrial Products Stocks Investing
- 3 Defensive Stocks Analysts Are Bullish on to Kick Off the Year
- 3 Healthcare Dividend Stocks to Buy
- Vistra Corp: Could 2025 Continue Its Streak of Outperformance?
- Compound Interest and Why It Matters When Investing
- Vertex’s Pain Drug: Big Pharma’s Next Major Success?
Receive News & Ratings for Gaia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gaia and related companies with MarketBeat.com's FREE daily email newsletter.